We are happy to announce that our society has successfully engaged in the initiative to change the name of Polycystic Ovary Syndrome (PCOS). Polyendocrine Metabolic Ovarian Syndrome (PMOS) is now the new name for the condition, which impacts 1 in 8, or more than 170 million women worldwide.

The AE- PCOS society leadership was part of the Name Change Steering Committee, and many of its members were involved in the rigorous process of selecting the new name.